VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹627 Cr | ₹601 Cr | ₹579 Cr | ₹556 Cr | ₹644 Cr |
What is the latest Total Liabilities ratio of VENUS REMEDIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹627 Cr |
Mar2023 | ₹601 Cr |
Mar2022 | ₹579 Cr |
Mar2021 | ₹556 Cr |
Mar2020 | ₹644 Cr |
How is Total Liabilities of VENUS REMEDIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹627 Cr | 4.28 | |
Mar2023 | ₹601 Cr | 3.79 | |
Mar2022 | ₹579 Cr | 4.19 | |
Mar2021 | ₹556 Cr | -13.66 | |
Mar2020 | ₹644 Cr | - |
Compare Total Liabilities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹398.2 Cr | 0.9% | -7.7% | -19.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 0.9% |
-7.7% |
-19.9% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses